Google parent company Alphabet Inc. has launched a new company in London called Isomorphic Labs. The company aims to use AI (artificial intelligence) for drug discovery and medicine to find cures for some of humanity’s most devastating diseases. Demis Hassabis will be the CEO of Isomorphic Labs. Hassabis is the CEO and co-founder of DeepMind, another Alphabet subsidiary that used AI to predict the 3D structure of a protein directly from its amino acid sequence.
The London-based Isomorphic Labs will work on the most important applications of AI — in the field of biological and medical research. The company aims to use AI to accelerate drug discovery, and ultimately, find cures for some of humanity’s most devastating diseases. The new venture also plans to partner with biomedical and pharmaceutical companies, using artificial intelligence to discover new medicinal advancements.
Important takeaways for all competitive exams
The 14th edition of the cricket's premier ODI tournament, The ICC Men’s Cricket World Cup…
National News Oilseeds Kisaan Mitra: India's First WhatsApp AI Advisory for Oilseed Cultivation The Indian…
The Invest India and Invest UP have entered into the strategic partnership to attract the…
The Indian Institute of Technology (IIT) Bhubaneswar have developed the "ArsenSafe," a portable device which is…
The Jawaharlal Nehru Port Authority (JNPA) has emerged as the India's best-performing container port in…
The Central Government has appointed the Mr. Sanjay Lohiya, Secretary of the Department of Financial…